Read by QxMD icon Read

Drug burden index

Kris M Jamsen, Danijela Gnjidic, Sarah N Hilmer, Jenni Ilomäki, David G Le Couteur, Fiona M Blyth, David J Handelsman, Vasi Naganathan, Louise M Waite, Robert G Cumming, J Simon Bell
OBJECTIVE: Anticholinergic and sedative medications are associated with acute cognitive impairment but the long-term impact on change in cognition is unclear. This study investigated the effect of anticholinergic and sedative medications, quantified using the Drug Burden Index (DBI), on change in cognition over time in community-dwelling older men. METHODS: This was a prospective cohort study of men aged ≥70 years in Sydney, Australia. DBI was assessed at baseline, two and five years...
October 20, 2016: Annals of Medicine
Bishnu Joshi, Sarah Hendrickx, Lila Bahadur Magar, Niranjan Parajuli, Pierre Dorny, Louis Maes
BACKGROUND: Nepal is very rich in biodiversity, and no extensive effort has yet been carried out to screen plants that are used by traditional healers against parasitic diseases. The aim of this study was to evaluate the in vitro antileishmanial and antimalarial activity of crude methanolic or ethanolic extracts of 29 plant species that are currently used by local people of Nepal for treating different ailments. METHODS: Crude extracts of leaves, twigs, aerial parts, and/or roots of the selected plants were evaluated for in vitro inhibitory activity against intracellular amastigotes of Leishmania infantum and against erythrocytic stages of Plasmodium falciparum...
September 2016: Journal of Intercultural Ethnopharmacology
Daniel V Mogford, Rebecca J Lawrence
Aims and method To investigate the burden of medical comorbidity in a population receiving in-patient treatment for drug and alcohol problems. All patients admitted over a 6-month period were included in the data-set. We recorded diagnostic information on admission that allowed the calculation of predicted 10-year survival using a previously validated comorbidity index. Results Despite the majority of the sample having a predicted 10-year survival chance of greater than 75%, a sizeable minority (16.7%) are carrying a high burden of medical comorbidity, with a predicted 10-year survival chance of less than 50%...
October 2016: BJPsych Bulletin
Sergio Iannazzo, Gianluca Furneri, Federica Demma, Chiara Distante, Simone Parisi, Veronica Berti, Enrico Fusaro
INTRODUCTION: Chronic inflammatory rheumatic diseases (RDs) trigger high costs for healthcare systems and society due to the disability and comorbidity associated with these disease entities. The aim of this study was to analyze patients with RD, assess the use of conventional synthetic and biologic therapies, and estimate the overall cost of treatment in Italy. METHODS: Administrative healthcare claims from the Piedmont region in Northwest Italy were reviewed to identify patients who received disease-modifying antirheumatic drugs (DMARDs) between 2007 and 2010...
June 2016: Rheumatol Ther
Tanja Mayer, Jürgen Kopitz, Konstanze Plaschke, Johanna Weiss, Hanna M Seidling, Walter E Haefeli
OBJECTIVE: The anticholinergic activity (AA) assay is a common method to determine a patient's anticholinergic load. Several limitations, however, are expected when applying the AA assay to patients or using drug scales to estimate anticholinergic burden based on AA levels. This study aims to demonstrate common pitfalls in an experimental setting and outline their clinical consequences. METHODS: The AA was analyzed for five drugs with reported interaction with muscarinic receptors...
August 4, 2016: American Journal of Geriatric Psychiatry
(no author information available yet)
BACKGROUND: The Global Burden of Diseases, Injuries, and Risk Factors Study 2015 provides an up-to-date synthesis of the evidence for risk factor exposure and the attributable burden of disease. By providing national and subnational assessments spanning the past 25 years, this study can inform debates on the importance of addressing risks in context. METHODS: We used the comparative risk assessment framework developed for previous iterations of the Global Burden of Disease Study to estimate attributable deaths, disability-adjusted life-years (DALYs), and trends in exposure by age group, sex, year, and geography for 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks from 1990 to 2015...
October 8, 2016: Lancet
(no author information available yet)
BACKGROUND: Healthy life expectancy (HALE) and disability-adjusted life-years (DALYs) provide summary measures of health across geographies and time that can inform assessments of epidemiological patterns and health system performance, help to prioritise investments in research and development, and monitor progress toward the Sustainable Development Goals (SDGs). We aimed to provide updated HALE and DALYs for geographies worldwide and evaluate how disease burden changes with development...
October 8, 2016: Lancet
(no author information available yet)
BACKGROUND: Improving survival and extending the longevity of life for all populations requires timely, robust evidence on local mortality levels and trends. The Global Burden of Disease 2015 Study (GBD 2015) provides a comprehensive assessment of all-cause and cause-specific mortality for 249 causes in 195 countries and territories from 1980 to 2015. These results informed an in-depth investigation of observed and expected mortality patterns based on sociodemographic measures. METHODS: We estimated all-cause mortality by age, sex, geography, and year using an improved analytical approach originally developed for GBD 2013 and GBD 2010...
October 8, 2016: Lancet
Shengli Ma, Xue Rui, Peiyi Qi, Gangqiong Liu, Jing Yang
BACKGROUND: Poor sleep is common in patients with multiple sclerosis (MS). This study assessed the prevalence of poor sleep and investigated the potential impact factors that influence sleep quality of patients with MS. METHODS: A cross-sectional self-report survey of 231 patients with MS and 265 sex- and age-matched controls was conducted. Good sleepers and poor sleepers were separated by their global score on the Pittsburgh Sleep Quality Index (PSQI). Sociodemographic parameters, such as age, gender, and marital status, and clinical-demographic parameters, such as excessive daytime sleepiness (measured by the Epworth Sleepiness Scale), snoring, insomnia, obstructive sleep apnea, drugs, pain, depression, fatigue, and quality of life, were registered...
October 11, 2016: Sleep & Breathing, Schlaf & Atmung
Daniel Sevilla-Sanchez, Núria Molist-Brunet, Jordi Amblàs-Novellas, Pere Roura-Poch, Joan Espaulella-Panicot, Carles Codina-Jané
PURPOSE: Adverse drug events (ADEs) lead to adverse clinical outcomes such as hospitalization. There is little information about the characteristics of ADEs in patients with advanced chronic conditions and have a prognosis of limited life expectancy. This study aimed to evaluate (i) the prevalence of ADEs at the time of admission to hospital, (ii) the causality, severity, and preventability of the ADEs, and (iii) the clinical and pharmacological characteristics associated with the ADEs...
October 4, 2016: European Journal of Clinical Pharmacology
Tomasz Roleder, Keyvan Karimi Galougahi, Chee Yang Chin, Navdeep K Bhatti, Emmanouil Brilakis, Tamim M Nazif, Ajay J Kirtane, Dimitri Karmpaliotis, Wojciech Wojakowski, Martin B Leon, Gary S Mintz, Akiko Maehara, Gregg W Stone, Ziad A Ali
AIMS: Near-infrared spectroscopy (NIRS) has been employed to assess the composition of the atherosclerotic plaques in native coronary arteries. However, little is known about the detection of neoatherosclerosis by NIRS in in-stent restenosis (ISR). The aim of the study was to assess the relationship between the distribution of lipid determined by NIRS and morphology of ISR on optical coherence tomography (OCT). METHODS AND RESULTS: We performed both NIRS and OCT in 39 drug-eluting stents with ISR...
September 27, 2016: European Heart Journal Cardiovascular Imaging
Sophie Béliard, Aurélie Millier, Valérie Carreau, Alain Carrié, Philippe Moulin, Alexandre Fredenrich, Michel Farnier, Gérald Luc, David Rosenbaum, Mondher Toumi, Eric Bruckert
BACKGROUND: Heterozygous familial hypercholesterolemia (heFH) is a genetic disease causing high levels of low-density lipoprotein cholesterol (LDL-C). Although this population is at high cardiovascular (CV) risk, the risk is variable within patients depending on additional risk factors. CV disease risk groups have been defined by the Nouvelle Société Francophone d'Athérosclérose (NSFA) and by the National Lipid Association recommendations. OBJECTIVES: The study aimed to describe a sample of French heFH patients, comparing patients at very high risk (VHR) and patients at high risk in terms of demographic and clinical characteristics as well as biological measurements and disease management...
September 2016: Journal of Clinical Lipidology
Innocent Lule Segamwenge, Ngalyuka Paul Kioko, Celia Mukulu, Ogunsina Jacob, Wanzira Humphrey, Josephine Augustinus
INTRODUCTION: Neurocysticercosis is a common cause of seizures in low resource countries. There is a paucity of data regarding the extent of this infection in Namibia. There are multiple causes of First-time seizure including electrolyte abnormalities, infections, trauma, drugs, alcohol and many times no apparent cause can be found. We sought to describe the burden of Neurocysticercosis among individuals with a first-time seizure in Namibia. METHODS: We recruited 221 patients with a First-time seizure who presented to the Intermediate Hospital Oshakati between August 2012 and March 2014...
2016: Pan African Medical Journal
Deborah Morrison, Karolina Agur, Stewart Mercer, Andreia Eiras, Juan I González-Montalvo, Kevin Gruffydd-Jones
The term multimorbidity is usually defined as the coexistence of two or more chronic conditions within an individual, whereas the term comorbidity traditionally describes patients with an index condition and one or more additional conditions. Multimorbidity of chronic conditions markedly worsens outcomes in patients, increases treatment burden and increases health service costs. Although patients with chronic respiratory disease often have physical comorbidities, they also commonly experience psychological problems such as depression and anxiety...
September 15, 2016: NPJ Primary Care Respiratory Medicine
Nazia Rashid, Puza P Sharma, Ronald D Scott, Kathy J Lin, Peter P Toth
OBJECTIVE: To evaluate patient characteristics, treatment patterns, comorbidities, and risk factors associated with the development of acute pancreatitis (AP) in patients with severe hypertriglyceridemia (HTG) in an integrated health care delivery system. METHODS: We identified a retrospective cohort of severe HTG patients with a fasting triglyceride level ≥ 1000 mg/dL during January 1, 2007 to June 30, 2013 (index date) in an integrated health care delivery system...
July 2016: Journal of Clinical Lipidology
Ali H Mokdad, Mohammad Hossein Forouzanfar, Farah Daoud, Charbel El Bcheraoui, Maziar Moradi-Lakeh, Ibrahim Khalil, Ashkan Afshin, Marwa Tuffaha, Raghid Charara, Ryan M Barber, Joseph Wagner, Kelly Cercy, Hannah Kravitz, Matthew M Coates, Margaret Robinson, Kara Estep, Caitlyn Steiner, Sara Jaber, Ali A Mokdad, Kevin F O'Rourke, Adrienne Chew, Pauline Kim, Mohamed Magdy Abd El Razek, Safa Abdalla, Foad Abd-Allah, Jerry P Abraham, Laith J Abu-Raddad, Niveen M E Abu-Rmeileh, Abdulwahab A Al-Nehmi, Ali S Akanda, Hanan Al Ahmadi, Mazin J Al Khabouri, Faris H Al Lami, Zulfa A Al Rayess, Deena Alasfoor, Fadia S AlBuhairan, Saleh F Aldhahri, Suliman Alghnam, Samia Alhabib, Nawal Al-Hamad, Raghib Ali, Syed Danish Ali, Mohammad Alkhateeb, Mohammad A AlMazroa, Mahmoud A Alomari, Rajaa Al-Raddadi, Ubai Alsharif, Nihaya Al-Sheyab, Shirina Alsowaidi, Mohamed Al-Thani, Khalid A Altirkawi, Azmeraw T Amare, Heresh Amini, Walid Ammar, Palwasha Anwari, Hamid Asayesh, Rana Asghar, Ali M Assabri, Reza Assadi, Umar Bacha, Alaa Badawi, Talal Bakfalouni, Mohammed O Basulaiman, Shahrzad Bazargan-Hejazi, Neeraj Bedi, Amit R Bhakta, Zulfiqar A Bhutta, Aref A Bin Abdulhak, Soufiane Boufous, Rupert R A Bourne, Hadi Danawi, Jai Das, Amare Deribew, Eric L Ding, Adnan M Durrani, Yousef Elshrek, Mohamed E Ibrahim, Babak Eshrati, Alireza Esteghamati, Imad A D Faghmous, Farshad Farzadfar, Andrea B Feigl, Seyed-Mohammad Fereshtehnejad, Irina Filip, Florian Fischer, Fortuné G Gankpé, Ibrahim Ginawi, Melkamu Dedefo Gishu, Rahul Gupta, Rami M Habash, Nima Hafezi-Nejad, Randah R Hamadeh, Hayet Hamdouni, Samer Hamidi, Hilda L Harb, Mohammad Sadegh Hassanvand, Mohammad T Hedayati, Pouria Heydarpour, Mohamed Hsairi, Abdullatif Husseini, Nader Jahanmehr, Vivekanand Jha, Jost B Jonas, Nadim E Karam, Amir Kasaeian, Nega Assefa Kassa, Anil Kaul, Yousef Khader, Shams Eldin A Khalifa, Ejaz A Khan, Gulfaraz Khan, Tawfik Khoja, Ardeshir Khosravi, Yohannes Kinfu, Barthelemy Kuate Defo, Arjun Lakshmana Balaji, Raimundas Lunevicius, Carla Makhlouf Obermeyer, Reza Malekzadeh, Morteza Mansourian, Wagner Marcenes, Habibolah Masoudi Farid, Alem Mehari, Abla Mehio-Sibai, Ziad A Memish, George A Mensah, Karzan A Mohammad, Ziad Nahas, Jamal T Nasher, Haseeb Nawaz, Chakib Nejjari, Muhammad Imran Nisar, Saad B Omer, Mahboubeh Parsaeian, Emmanuel K Peprah, Aslam Pervaiz, Farshad Pourmalek, Dima M Qato, Mostafa Qorbani, Amir Radfar, Anwar Rafay, Kazem Rahimi, Vafa Rahimi-Movaghar, Sajjad Ur Rahman, Rajesh K Rai, Saleem M Rana, Sowmya R Rao, Amany H Refaat, Serge Resnikoff, Gholamreza Roshandel, Georges Saade, Mohammad Y Saeedi, Mohammad Ali Sahraian, Shadi Saleh, Lidia Sanchez-Riera, Maheswar Satpathy, Sadaf G Sepanlou, Tesfaye Setegn, Amira Shaheen, Saeid Shahraz, Sara Sheikhbahaei, Kawkab Shishani, Karen Sliwa, Mohammad Tavakkoli, Abdullah S Terkawi, Olalekan A Uthman, Ronny Westerman, Mustafa Z Younis, Maysaa El Sayed Zaki, Faiez Zannad, Gregory A Roth, Haidong Wang, Mohsen Naghavi, Theo Vos, Abdullah A Al Rabeeah, Alan D Lopez, Christopher J L Murray
BACKGROUND: The eastern Mediterranean region is comprised of 22 countries: Afghanistan, Bahrain, Djibouti, Egypt, Iran, Iraq, Jordan, Kuwait, Lebanon, Libya, Morocco, Oman, Pakistan, Palestine, Qatar, Saudi Arabia, Somalia, Sudan, Syria, Tunisia, the United Arab Emirates, and Yemen. Since our Global Burden of Disease Study 2010 (GBD 2010), the region has faced unrest as a result of revolutions, wars, and the so-called Arab uprisings. The objective of this study was to present the burden of diseases, injuries, and risk factors in the eastern Mediterranean region as of 2013...
October 2016: Lancet Global Health
Pak-Hei Chan, Jo-Jo Hai, Duo Huang, Mei-Han Ho, Esther W Chan, Bernard Man-Yung Cheung, Annie On-On Chan, Ian Chi-Kei Wong, Hung-Fat Tse, Ivan Fan-Ngai Hung, Chung-Wah Siu
BACKGROUND: Dabigatran, a non-vitamin K antagonist oral anticoagulant, has been shown to prevent stroke in patients with non-valvular atrial fibrillation. Nonetheless, studies show that 10%-30% of those prescribed dabigatran experience dyspepsia that may eventually lead to discontinuation of therapy and loss of clinical benefit. AIM: To evaluate the gastrointestinal tolerability of dabigatran utilizing a validated questionnaire, as well as determining subsequent non-compliance and drug discontinuation...
2016: SAGE Open Medicine
Liesl Grobler, Shaheen Mehtar, Keertan Dheda, Shahieda Adams, Sanni Babatunde, Martie van der Walt, Muhammad Osman
BACKGROUND: In South Africa, workplace acquired tuberculosis (TB) is a significant occupational problem among health care workers. In order to manage the problem effectively it is important to know the burden of TB in health care workers. This systematic review describes the epidemiology of TB in South African health care workers. METHODS: A comprehensive search of electronic databases [MEDLINE, EMBASE, Web of Science (Social Sciences Citation Index/Science Citation Index), Cochrane Library (including CENTRAL register of Controlled Trials), CINAHL and WHO International Clinical Trials Registry Platform (ICTRP)] was conducted up to April 2015 for studies reporting on any aspect of TB epidemiology in health care workers in South Africa...
2016: BMC Health Services Research
R Mameniškienė, I Karmonaitė, R Zagorskis
PURPOSE: To investigate and classify headaches in adult people with epilepsy, to evaluate the burden of headaches, and to compare findings with a population-based epidemiological study. METHODS: Two hundred eighty (61.4% women) people with epilepsy (mean age 37.8±14.5, mean duration of epilepsy 13.2±11.9years) completed a questionnaire collecting socio-demographic and clinical data, questions clarifying their type of a headache, a Qolie-10 questionnaire and a Headache-Attributed Lost Time (HALT) index...
October 2016: Seizure: the Journal of the British Epilepsy Association
Jeffrey M Cohen, Kareem Halim, Cara J Joyce, Mital Patel, Abrar A Qureshi, Joseph F Merola
While burden of disease (BOD) data exists for plaque psoriasis, and to a lesser extent other phenotypes of psoriasis, there is no published data on the impact of inverse (intertriginous) psoriasis. We sought to assess the overall BOD among patients with inverse psoriasis (IP). We introduce the Inverse Psoriasis Burden of Disease (IPBOD) questionnaire and compare it to the Dermatology Life Quality Index (DLQI). In this cross-sectional pilot study, we administered the IPBOD and the DLQI to 16 patients. We present the initial psychometric properties of the IPBOD survey...
August 1, 2016: Journal of Drugs in Dermatology: JDD
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"